Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rosario Alessandro Cavasio"'
Autor:
Alessandra Imeneo, Lorenzo Vittorio Rindi, Andrea Di Lorenzo, Rosario Alessandro Cavasio, Pietro Vitale, Ilaria Spalliera, Mario Dauri, Daniele Guerino Biasucci, Ilaria Giuliano, Cartesio D’Agostini, Silvia Minelli, Maria Cristina Bossa, Anna Altieri, Massimo Andreoni, Vincenzo Malagnino, Marco Iannetta, Loredana Sarmati
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Actinomyces turicensis is rarely responsible of clinically relevant infections in human. Infection is often misdiagnosed as malignancy, tuberculosis, or nocardiosis, therefore delaying the correct identification and treatment. Her
Externí odkaz:
https://doaj.org/article/7f6a68e66aeb498b9999712860e883dd
Autor:
Benedetta Rossi, Filippo Barreca, Domenico Benvenuto, Neva Braccialarghe, Laura Campogiani, Alessandra Lodi, Camilla Aguglia, Rosario Alessandro Cavasio, Maria Laura Giacalone, Dimitra Kontogiannis, Martina Moccione, Vincenzo Malagnino, Massimo Andreoni, Loredana Sarmati, Marco Iannetta
Publikováno v:
Viruses, Vol 15, Iss 2, p 368 (2023)
Arboviruses represent a public health concern in many European countries, including Italy, mostly because they can infect humans, causing potentially severe emergent or re-emergent diseases, with epidemic outbreaks and the introduction of endemic cir
Externí odkaz:
https://doaj.org/article/dab6ea31ed154b7ca71306e86311509d
Autor:
Neva Braccialarghe, Rosario Alessandro Cavasio, Drieda Zaçe, Ilaria Spalliera, Luigi Coppola, Iannetta Marco, Loredana Sarmati, Massimo Andreoni
Publikováno v:
Open Forum Infectious Diseases. 9
Background Since the outbreak of COVID-19 pandemic the scientific community efforts have been focused on finding a vaccine and a treatment for infected people. Several antivirals with activity against SARS-CoV-2 were investigated and since the end of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e487d5a77b03963abcedc412fa1c0c1e
https://doi.org/10.1093/ofid/ofac492.977
https://doi.org/10.1093/ofid/ofac492.977
Autor:
Rosario Alessandro Cavasio, Neva Braccialarghe, Drieda Zaçe, Ilaria Spalliera, Luigi Coppola, Laura Campogiani, Lorenzo Piermatteo, Maria Concetta Bellocchi, Francesca Ceccherini Silberstein, Iannetta Marco, Loredana Sarmati, Massimo Andreoni
Publikováno v:
Open Forum Infectious Diseases. 9
Background To cope with the SARS-CoV-2 pandemic, several treatments were studied and out of these, monoclonal antibodies (MAbs) have shown efficacy to prevent the development of pneumonia after the infection Methods We conducted a retrospective, sing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29abab3c40713cbb47a4d2f55d7d7235
https://doi.org/10.1093/ofid/ofac492.358
https://doi.org/10.1093/ofid/ofac492.358